重组人血小板生成素在成人原发免疫性血小板减少症患者围手术期的应用

OBJECTIVE: To evaluate the efficacy and safety of recombinant human thrombopoietin (rhTPO) treatment for primary immune thrombocytopenia (ITP) patients during the perioperative period. METHODS: Adult ITP patients who were refractory to first-line glucocorticoid therapy and underwent selective surger...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342530/
https://www.ncbi.nlm.nih.gov/pubmed/30929384
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342530/
https://www.ncbi.nlm.nih.gov/pubmed/30929384
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.03.005

Ejemplares similares